AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 33,906 | 1,508 | 75,312 | 1,415 | 2,343 |
| Gross Profit | 33,906 | 1,508 | 75,312 | 1,415 | 2,343 |
| Operating Expenses | 15,662 | 16,249 | 14,940 | 16,014 | 14,715 |
| Operating Income | 18,243 | -14,742 | 60,373 | -14,599 | -12,372 |
| Interest Expense | 87 | 503 | 1,180 | -46 | 32 |
| Other Income | 327 | -1,617 | 4,611 | -236 | -1,336 |
| Pre-tax Income | 18,483 | -16,862 | 63,803 | -14,789 | -13,739 |
| Net Income Continuous | 18,483 | -16,862 | 63,803 | -14,789 | -13,739 |
| Net Income | $18,483 | $-16,862 | $63,803 | $-14,789 | $-13,739 |
| EPS Basic Total Ops | 0.25 | -0.24 | 0.94 | -0.22 | -0.21 |
| EPS Basic Continuous Ops | 0.26 | -0.24 | 0.94 | -0.22 | -0.21 |
| EPS Diluted Total Ops | 0.25 | -0.24 | 0.91 | -0.22 | -0.21 |
| EPS Diluted Continuous Ops | 0.26 | -0.24 | 0.90 | -0.22 | -0.21 |
| EBITDA(a) | $18,585 | $-14,452 | $60,666 | $-14,323 | $-12,115 |